Alvarez-Erviti and colleagues demonstrated that engineered EVs containing small interfering RNA (siRNA) and injected in blood vessels could pass the BBB and interfere with genes involved in the synthesis of amyloid precursor protein in a mouse model of Alzheimer’s disease [95]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.